Cinepazide maleate cas no:26328-04-1
Synonyms: Piperazine,1-[2-oxo-2-(1-pyrrolidinyl)ethyl]- 4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2- propenyl]-,(2Z)-2-butenedioate (1:1);1-(2-Oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)piperazine (Z)-2-butenedioate (1:1);MD 67350;Vasodistal;Brendil;1-(4-((3,4,5-Trimethoxycinnamoyl)-1-piperazinyl)acetyl)pyrrolidine maleate;1-((1-Pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine maleate;Piperazine, 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)-, maleate;Cinepazide maleate (JAN);
NameCinepazide maleate
CAS26328-04-1
SynonymsPiperazine,1-[2-oxo-2-(1-pyrrolidinyl)ethyl]- 4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2- propenyl]-,(2Z)-2-butenedioate (1:1);1-(2-Oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)piperazine (Z)-2-butenedioate (1:1);MD 67350;Vasodistal;Brendil;1-(4-((3,4,5-Trimethoxycinnamoyl)-1-piperazinyl)acetyl)pyrrolidine maleate;1-((1-Pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine maleate;Piperazine, 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)-, maleate;Cinepazide maleate (JAN);
EINECS(EC#)247-613-1
Molecular FormulaC22H31N3O5.C4H4O4
Molecular Weight533.57
AppearanceWhite or off-white crystalline powder.
Safety
Moderately toxic by ingestion, subcutaneous, and intravenous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| mouse |
LD50 |
intravenous |
617mg/kg (617mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: ANTIPSYCHOTIC |
Therapie. Vol. 29, Pg. 29, 1974. |
| mouse |
LD50 |
oral |
1gm/kg (1000mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: ANTIPSYCHOTIC |
Therapie. Vol. 29, Pg. 29, 1974. |
| mouse |
LD50 |
subcutaneous |
946mg/kg (946mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 407, 1979. |
| rat |
LD50 |
intravenous |
414mg/kg (414mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: ANTIPSYCHOTIC |
Therapie. Vol. 29, Pg. 29, 1974. |
| rat |
LD50 |
oral |
1310mg/kg (1310mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: ANTIPSYCHOTIC |
Therapie. Vol. 29, Pg. 29, 1974. |
| rat |
LD50 |
subcutaneous |
710mg/kg (710mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 407, 1979. |
